News | Wearables | October 15, 2021

Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series

The Biotricity Biocare Cardiac app for the Samsung Galaxy Watch4 offers mobile cardiac telemetry with real-time monitoring and transmission of ECG information. It also can interface with FDA-cleared devices, including a digital thermometer, a pulse oximeter and a blood pressure cuff.

The Biotricity Biocare Cardiac app for the Samsung Galaxy Watch4 offers mobile cardiac telemetry with real-time monitoring and transmission of ECG information. It also can interface with FDA-cleared devices, including a digital thermometer, a pulse oximeter and a blood pressure cuff.


October 15, 2021 — Biotricity Inc. announced the release of Biocare Cardiac, a personal, cardiac health application for individuals diagnosed with or at risk for cardiovascular disease. Designed to be used with Samsung's Galaxy Watch4 smartwatch series, the Biocare Cardiac application continuously collects users' daily activities and provides critical information on their heart performance, empowering patients to better understand and manage their heart conditions. 

Many at-risk cardiac patients only visit a doctor every six months to a year and have limited tools and resources to help them manage their cardiac health every day. The new application is designed to help patients between doctor visits by engaging with a wearable device to help them in lifestyle management activities in a way that will help their doctors make diagnoses augmented with daily medical data related to ECG, SpO2, heart rate, weight and details on fitness and exercise.

"Wearable devices have incredible potential in the healthcare industry, giving individuals information to use in conversations with their doctors and gain a better understanding of their health. The Biocare Cardiac application for Samsung's Galaxy Watch4 series is a great example of this. The application can help make it easier for at-risk individuals to monitor their cardiac health with their doctor and make healthy lifestyles decisions to enhance their quality of life," said Dr. Hon Pak, chief medical officer, Samsung Electronics America.

This new application is designed to be used as part of Biotricity's complete cardiac solution. This includes:
   • Biocare Telemed: a virtual clinic platform with secure HIPAA compliant technology that enables patients to receive care from cardiac physicians remotely.
   • Bioflux Diagnostics: a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ECG information.
   • Biokit: a personal medical device kit bundled for home-use comprised of FDA approved devices including a digital thermometer, a pulse oximeter, a blood pressure cuff and now, the Galaxy Watch4 series.
   • Bioheart: a personal, consumer heart monitor for long-term heart rhythm data collection.
   • Galaxy Watch4 Series: Equipped with an advanced suite of health and wellness features, including the ability to detect an AFib irregular heartbeat, measure blood oxygen level, calculate body composition and track physical activity. This is Samsung's first smartwatch to feature the new Wear OS Powered by Samsung, built jointly with Google.

Biocare Cardiac and Biocare Telemed are fully compatible with Google Wear OS, Android, and iOS and can be downloaded via the App Store or the Play Store.

Biocare Cardiac and Telemed offer full lifecycle care for individuals interested in improving their heart health. If an individual or a loved one is concerned about their heart health, they can pre-download Biocare Cardiac via the Google Play Store or the Apple App Store and stay up to date as we launch.

For more information: www.biotricity.com

Find more technology news on cardiac wearable devices


Related Content

News | Cardiac Diagnostics

Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for ...

Home August 15, 2024
Home
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Subscribe Now